The voluntary program assures brand manufacturers that the ingredients have been routinely tested for a range of prohibited substances, and therefore safe for use by athletes.
Taiyo (Minneapolis, MN) has announced that its ingredients Sunfiber, Suntheanine, Matcha, and Teavigo have received Informed Ingredient certification from LGC (Lexington, KY). The voluntary program assures brand manufacturers that the ingredients have been routinely tested for a range of prohibited substances, and therefore safe for use by athletes. The move helps Taiyo’s customers comply with Amazon’s dietary supplement safety documentation, and Taiyo anticipates expanding the Informed Ingredient certification to some of its other ingredients.
“The momentum is shifting on the ingredient side,” said LGC’s business development director Paul Klinger, in a press release. “Reputable ingredient suppliers are doing more than just testing to see if their products are safe. Informed Ingredient certification adds an additional level of credibility and quality assurance to their brands, which further distinguishes them from their competition.”
“Informed Ingredient certification provides our customers with the additional confidence that when they use our brands in their formulas, they are not just effective, but they are also safe for athletes to use,” said Scott Smith, Taiyo International’s vice president. “Taiyo stands ready to help our customers with their Informed Choice certification and Amazon compliance.”
The Informed Ingredient certification is the first step in LGC’s Informed Choice certification, which in addition to evaluating raw materials and manufacturing processes, also involved monthly retail monitoring and testing. The Informed Choice certification is one Amazon’s approved third-party quality certification programs required for the sale of dietary supplements on the site.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.